Palisades Investment Partners’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-48,100	Closed	-$1.13M	–	79
2013 Q3	$1.13M	Hold	48,100	–	–	1.06%	41
2013 Q2	$1.29M	Buy	+48,100	New	+$1.29M	1.28%	32